Conciseness

The body is dense and token-efficient: tool lists with parameter gotchas, tables, and checklists with almost no teaching of concepts Claude already knows. Score 4 rather than 5 because explanatory prose blocks (the KLIFS "Why DFG/alphaC state matters" paragraph, the four-gate rationale paragraphs) could be tightened or moved to a reference file; not 3 since there is no padded or redundant section.

Actionability

Concrete throughout: exact tool names with required parameters flagged ("operation=\"median\" REQUIRED"), known parameter corrections ("param: id, NOT uniprot_id"), a complete executable Python fallback snippet, and example output tables. Not 5 because the score computation itself is delegated entirely to SCORING_CRITERIA.md (absent from the bundle) and Phase 6's "Assess: pathway redundancy, compensation risk, feedback loops" is direction without method; not 3 because the guidance is overwhelmingly executable.

Workflow Clarity

Ten ordered phases with Phase 0 mandatory first, explicit gating ("Do not proceed to Phase 3 (Chemical Matter) before completing Phase 1"), collision detection in Phase 9, a documented MCP-to-SDK fallback chain with failure conditions, and a mandatory Completeness Checklist before finalizing. Matches the 5 anchor: clear sequence, explicit validation steps, feedback loops, and a checklist for a complex process.

Progressive Disclosure

A "Reference Files" section clearly signals four one-level-deep files, but none of them (SCORING_CRITERIA.md, REPORT_TEMPLATE.md, TOOL_REFERENCE.md, QUICK_START.md) exist in the bundle, so navigation dead-ends at runtime. Additionally, substantial detail that belongs in those files (the ADMET endpoint table, the KLIFS sub-guide, the ML attribution table) is inlined. Fits the 3 anchor (content that should be separate is inline; references present but not resolvable) better than 4, whose references must be real and mostly appropriately placed.

Specificity

Lists five concrete capabilities ("Scores druggability, selectivity, safety profile, ADMET feasibility, and structural tractability") plus a quantified output ("composite Target Validation Score (0-100) and GO/NO-GO recommendation"). Comprehensive with no generic filler, matching the 5 anchor; it is not 4 because no action is vague or missing.

Completeness

Explicitly answers both: a clear quantified "what" (multi-dimension scoring pipeline with 0-100 score and recommendation) and an explicit "Use for..." clause naming three concrete triggers. Matches the 5 anchor; the "when" is explicit rather than weakly implied, ruling out 4.

Trigger Term Quality

Natural phrases users would say are present: "go/no-go decisions on a target", "target prioritization across a list", "target-deselection rationale". It is not 3 (multiple natural phrasings, not jargon-only) and not 5 because common user phrasings like "Is this a good drug target?" or plain "druggability" are absent.

Distinctiveness Conflict Risk

"before commit-to-medchem" and "target-deselection rationale" carve a distinct validation-decision niche with triggers that do not bleed into general target research or compound profiling. Clear niche with distinct triggers and minimal conflict risk, matching the 5 anchor.